Works matching IS 00207136 AND DT 2022 AND VI 151 AND IP 8

Results: 22
    1

    Platinum sensitivity in patients with IDH1/2 mutated vs wild‐type intrahepatic cholangiocarcinoma: A propensity score‐based study.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1310, doi. 10.1002/ijc.34182
    By:
    • Niger, Monica;
    • Nichetti, Federico;
    • Casadei‐Gardini, Andrea;
    • Rizzato, Mario Domenico;
    • Pircher, Chiara;
    • Bini, Marta;
    • Franza, Andrea;
    • Rimini, Margherita;
    • Burgio, Valentina;
    • Sposetti, Caterina;
    • Fornaro, Lorenzo;
    • Rapposelli, Ilario Giovanni;
    • D'Amico, Francesco Enrico;
    • Aprile, Giuseppe;
    • Vivaldi, Caterina;
    • Frassineti, Giovanni Luca;
    • Milione, Massimo;
    • Leoncini, Giuseppe;
    • Cappetta, Alessandro;
    • Vasile, Enrico
    Publication type:
    Article
    2

    Expression Of Concern.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. E14, doi. 10.1002/ijc.34205
    Publication type:
    Article
    3
    4

    Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1405, doi. 10.1002/ijc.34159
    By:
    • Csizmarik, Anita;
    • Keresztes, Dávid;
    • Nagy, Nikolett;
    • Bracht, Thilo;
    • Sitek, Barbara;
    • Witzke, Kathrin;
    • Puhr, Martin;
    • Tornyi, Ilona;
    • Lázár, József;
    • Takács, László;
    • Kramer, Gero;
    • Sevcenco, Sabina;
    • Maj‐Hes, Agnieszka;
    • Jurányi, Zsolt;
    • Hadaschik, Boris;
    • Nyirády, Péter;
    • Szarvas, Tibor
    Publication type:
    Article
    5
    6
    7
    8
    9

    The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1248, doi. 10.1002/ijc.34145
    By:
    • Wu, Zeni;
    • Byrd, Doratha A.;
    • Wan, Yunhu;
    • Ansong, Daniel;
    • Clegg‐Lamptey, Joe‐Nat;
    • Wiafe‐Addai, Beatrice;
    • Edusei, Lawrence;
    • Adjei, Ernest;
    • Titiloye, Nicholas;
    • Dedey, Florence;
    • Aitpillah, Francis;
    • Oppong, Joseph;
    • Vanderpuye, Verna;
    • Osei‐Bonsu, Ernest;
    • Dagnall, Casey L.;
    • Jones, Kristine;
    • Hutchinson, Amy;
    • Hicks, Belynda D.;
    • Ahearn, Thomas U.;
    • Shi, Jianxin
    Publication type:
    Article
    10
    11

    Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1228, doi. 10.1002/ijc.34141
    By:
    • Harris, Holly R.;
    • Guertin, Kristin A.;
    • Camacho, Tareq F.;
    • Johnson, Courtney E.;
    • Wu, Anna H.;
    • Moorman, Patricia G.;
    • Myers, Evan;
    • Bethea, Traci N.;
    • Bandera, Elisa V.;
    • Joslin, Charlotte E.;
    • Ochs‐Balcom, Heather M.;
    • Peres, Lauren C.;
    • Rosenow, Will T.;
    • Setiawan, Veronica W.;
    • Beeghly‐Fadiel, Alicia;
    • Dempsey, Lauren F.;
    • Rosenberg, Lynn;
    • Schildkraut, Joellen M.
    Publication type:
    Article
    12
    13
    14

    Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1345, doi. 10.1002/ijc.34129
    By:
    • Pham, Fiona Y.‐V.;
    • Jacquet, Emmanuelle;
    • Taleb, Amina;
    • Monard, Adrien;
    • Kerouani‐Lafaye, Ghania;
    • Turcry, Florence;
    • Brunel, Liora;
    • Grudé, Françoise;
    • Yoldjian, Isabelle;
    • Sainte‐Marie, Isabelle;
    • Boudali, Lotfi;
    • Blay, Jean‐Yves;
    • Albin, Nicolas
    Publication type:
    Article
    15
    16

    Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1335, doi. 10.1002/ijc.34126
    By:
    • Vano, Yann‐Alexandre;
    • Phan, Letuan;
    • Gravis, Gwenaelle;
    • Korakis, Iphigénie;
    • Schlürmann, Friederike;
    • Maillet, Denis;
    • Bennamoun, Mostefa;
    • Houede, Nadine;
    • Topart, Delphine;
    • Borchiellini, Delphine;
    • Barthelemy, Philippe;
    • Ratta, Raffaele;
    • Ryckewaert, Thomas;
    • Hasbini, Ali;
    • Hans, Sophie;
    • Emambux, Sheik;
    • Cournier, Sandra;
    • Braychenko, Elena;
    • Elaidi, Réza‐Thierry;
    • Oudard, Stéphane
    Publication type:
    Article
    17

    Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1394, doi. 10.1002/ijc.34124
    By:
    • Koole, Simone N.;
    • Schouten, Philip C.;
    • Hauke, Jan;
    • Kluin, Roel J. C.;
    • Nederlof, Petra;
    • Richters, Lisa K.;
    • Krebsbach, Gabriele;
    • Sikorska, Karolina;
    • Alkemade, Maartje;
    • Opdam, Mark;
    • Schagen van Leeuwen, Jules H.;
    • Schreuder, Henk W. R.;
    • Hermans, Ralph H. M.;
    • de Hingh, Ignace H. J. T.;
    • Mom, Constantijne H.;
    • Arts, Henriette J. G.;
    • van Ham, Maaike;
    • van Dam, Peter;
    • Vuylsteke, Peter;
    • Sanders, Joyce
    Publication type:
    Article
    18
    19
    20
    21

    Issue Information.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1187, doi. 10.1002/ijc.33662
    Publication type:
    Article
    22

    Issue Information.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 8, p. 1420, doi. 10.1002/ijc.33661
    Publication type:
    Article